var singsData = [{"date":new Date(2012,1,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"DA Davidson maintains AKAM to Neutral. Target Price is $40; previously $36.","showOnAxis":true},{"date":new Date(2012,1,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains AKAM to Hold. Target Price is $41; previously $36.","showOnAxis":true},{"date":new Date(2012,1,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"PiperJaffray maintains AKAM to Neutral. Target Price is $36; previously $26.","showOnAxis":true},{"date":new Date(2012,1,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains AKAM to Buy. Target Price is $43; previously $32.","showOnAxis":true},{"date":new Date(2012,1,9),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"DA Davidson maintains AKAM to Neutral. Target Price is $40; previously $36.","showOnAxis":false},{"date":new Date(2012,1,9),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains AKAM to Hold. Target Price is $41; previously $36.","showOnAxis":false},{"date":new Date(2012,1,9),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"PiperJaffray maintains AKAM to Neutral. Target Price is $36; previously $26.","showOnAxis":false},{"date":new Date(2012,1,9),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains AKAM to Buy. Target Price is $43; previously $32.","showOnAxis":false},{"date":new Date(2012,10,14),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,10,14),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,11,11),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,11,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs assumes AKAM to Neutral. Target Price is $44.","showOnAxis":true},{"date":new Date(2012,11,12),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs assumes AKAM to Neutral. Target Price is $44.","showOnAxis":false},{"date":new Date(2012,2,14),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Oxen Group initiates coverage on AKAM to Hold. Target Price is $44.","showOnAxis":true},{"date":new Date(2012,2,14),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Oxen Group initiates coverage on AKAM to Hold. Target Price is $44.","showOnAxis":false},{"date":new Date(2012,3,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,3,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,3,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,3,26),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Jefferies upgrades AKAM to Buy from Hold. Target Price is $42; previously $41.","showOnAxis":false},{"date":new Date(2012,3,4),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"DA Davidson upgrades AKAM to Buy from Neutral. Target Price is $45; previously $40.","showOnAxis":false},{"date":new Date(2012,4,1),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, AKAM reports 2012 Q1's earning $0.24 per share and revenue $319.448MM..","showOnAxis":false},{"date":new Date(2012,4,16),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Citigroup upgrades AKAM to Neutral from Sell. Target Price is $32.","showOnAxis":false},{"date":new Date(2012,4,16),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,4,16),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2012,4,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Canaccord Genuity maintains AKAM to Hold. Target Price is $32; previously $34.","showOnAxis":true},{"date":new Date(2012,4,16),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Canaccord Genuity maintains AKAM to Hold. Target Price is $32; previously $34.","showOnAxis":false},{"date":new Date(2012,6,18),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,6,18),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,6,25),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"AKAM reports 2012 Q2's earning $0.43 per share and revenue $331MM. This beats analyst's estimated EPS $0.37, beats estimated revenue $325.74MM.","showOnAxis":false},{"date":new Date(2012,6,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,6,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,6,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,6,26),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Canaccord Genuity maintains AKAM to Hold. Target Price is $34; previously $32.","showOnAxis":true},{"date":new Date(2012,6,26),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Canaccord Genuity maintains AKAM to Hold. Target Price is $34; previously $32.","showOnAxis":false},{"date":new Date(2012,7,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Canaccord Genuity maintains AKAM to Hold. Target Price is $37; previously $34.","showOnAxis":true},{"date":new Date(2012,7,29),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Canaccord Genuity maintains AKAM to Hold. Target Price is $37; previously $34.","showOnAxis":false},{"date":new Date(2012,9,24),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, AKAM reports 2012 Q3's earning $0.43 per share and revenue $345MM. This beats analyst's estimated EPS $0.41, beats estimated revenue $338.2MM.","showOnAxis":false},{"date":new Date(2012,9,24),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,9,24),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,9,25),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Canaccord Genuity upgrades AKAM to Buy from Hold. Target Price is $45; previously $38.","showOnAxis":false},{"date":new Date(2012,9,25),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Oppenheimer upgrades AKAM to Outperform from Perform. Target Price is $50.","showOnAxis":false},{"date":new Date(2012,9,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains AKAM to Buy. Target Price is $44; previously $43.","showOnAxis":true},{"date":new Date(2012,9,25),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains AKAM to Buy. Target Price is $44; previously $43.","showOnAxis":false},{"date":new Date(2013,0,16),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,1,25),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Macquarie upgrades AKAM to Outperform from Neutral. Target Price is $42; previously $41.5.","showOnAxis":false},{"date":new Date(2013,1,6),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, AKAM reports 2012 Q4's earning $0.54 per share and revenue $378MM. This beats analyst's estimated EPS $0.5, misses estimated revenue $381.07MM.","showOnAxis":false},{"date":new Date(2013,1,6),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,1,6),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,1,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Janney Capital downgrades AKAM to Neutral from Buy.","showOnAxis":true},{"date":new Date(2013,1,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies downgrades AKAM to Hold from Buy. Target Price is $40; previously $44.","showOnAxis":true},{"date":new Date(2013,1,7),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Janney Capital downgrades AKAM to Neutral from Buy.","showOnAxis":false},{"date":new Date(2013,1,7),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies downgrades AKAM to Hold from Buy. Target Price is $40; previously $44.","showOnAxis":false},{"date":new Date(2013,10,8),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,10,8),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,11,2),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2013,11,2),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,2,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Oppenheimer maintains AKAM to Outperform. Target Price is $45; previously $48.","showOnAxis":true},{"date":new Date(2013,2,1),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Oppenheimer maintains AKAM to Outperform. Target Price is $45; previously $48.","showOnAxis":false},{"date":new Date(2013,2,15),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Maxim Group initiates coverage on AKAM to Buy. Target Price is $44.","showOnAxis":true},{"date":new Date(2013,2,15),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Maxim Group initiates coverage on AKAM to Buy. Target Price is $44.","showOnAxis":false},{"date":new Date(2013,2,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"FBN Securities initiates coverage on AKAM to Outperform. Target Price is $45.","showOnAxis":true},{"date":new Date(2013,2,20),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"FBN Securities initiates coverage on AKAM to Outperform. Target Price is $45.","showOnAxis":false},{"date":new Date(2013,3,12),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,3,24),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, AKAM reports 2013 Q1's earning $0.51 per share and revenue $368MM. This beats analyst's estimated EPS $0.47, beats estimated revenue $357.51MM.","showOnAxis":false},{"date":new Date(2013,3,24),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,3,24),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,3,25),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"JP Morgan upgrades AKAM to Overweight from Neutral. Target Price is $52; previously $42.","showOnAxis":false},{"date":new Date(2013,3,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"MKM Partners initiates coverage on AKAM to Buy. Target Price is $60.","showOnAxis":true},{"date":new Date(2013,3,30),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"MKM Partners initiates coverage on AKAM to Buy. Target Price is $60.","showOnAxis":false},{"date":new Date(2013,4,15),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,4,15),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,4,15),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2013,4,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"DA Davidson downgrades AKAM to Neutral from Buy. Target Price is $50.","showOnAxis":true},{"date":new Date(2013,4,29),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"DA Davidson downgrades AKAM to Neutral from Buy. Target Price is $50.","showOnAxis":false},{"date":new Date(2013,5,20),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,5,20),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,5,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains AKAM to Hold. Target Price is $44; previously $40.","showOnAxis":true},{"date":new Date(2013,5,3),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains AKAM to Hold. Target Price is $44; previously $40.","showOnAxis":false},{"date":new Date(2013,6,24),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"AKAM reports 2013 Q2's earning $0.46 per share and revenue $378MM. This meets analyst's estimated EPS $0.46, beats estimated revenue $374.15MM.","showOnAxis":false},{"date":new Date(2013,6,24),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,6,24),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,8,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"B. Riley downgrades AKAM to Neutral from Buy. Target Price is $55.","showOnAxis":true},{"date":new Date(2013,8,27),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"B. Riley downgrades AKAM to Neutral from Buy. Target Price is $55.","showOnAxis":false},{"date":new Date(2013,9,16),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"DA Davidson upgrades AKAM to Buy from Neutral. Target Price is $62.","showOnAxis":false},{"date":new Date(2013,9,23),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,9,23),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,9,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains AKAM to Hold. Target Price is $44; previously $45.","showOnAxis":true},{"date":new Date(2013,9,24),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains AKAM to Hold. Target Price is $44; previously $45.","showOnAxis":false},{"date":new Date(2014,0,1),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,0,31),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,1,12),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,1,12),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,1,13),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2014,1,13),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,1,13),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2014,1,13),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,1,13),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Unregistered Sales of Equity Securities\r\n","showOnAxis":true},{"date":new Date(2014,1,18),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Completion of Acquisition or Disposition of Assets\r\n","showOnAxis":true},{"date":new Date(2014,1,18),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,1,18),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,1,5),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Credit Suisse upgrades AKAM to Neutral from Underperform.","showOnAxis":false},{"date":new Date(2014,1,5),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,1,5),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,1,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"DA Davidson maintains AKAM to Buy. Target Price is $63; previously $62.","showOnAxis":true},{"date":new Date(2014,1,7),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"DA Davidson maintains AKAM to Buy. Target Price is $63; previously $62.","showOnAxis":false},{"date":new Date(2014,10,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JMP Securities initiates coverage on AKAM to Market Perform.","showOnAxis":true},{"date":new Date(2014,10,17),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"JMP Securities initiates coverage on AKAM to Market Perform.","showOnAxis":false},{"date":new Date(2014,11,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"DA Davidson maintains AKAM to Buy. Target Price is $86; previously $72.","showOnAxis":true},{"date":new Date(2014,11,30),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"DA Davidson maintains AKAM to Buy. Target Price is $86; previously $72.","showOnAxis":false},{"date":new Date(2014,3,10),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"B. Riley upgrades AKAM to Buy from Neutral. Target Price is $68; previously $52.","showOnAxis":false},{"date":new Date(2014,4,1),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,4,1),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,4,14),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Pacific Crest upgrades AKAM to Outperform from Sector Perform. Target Price is $65.","showOnAxis":false},{"date":new Date(2014,4,14),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2014,4,14),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"B. Riley maintains AKAM to Buy. Target Price is $68.","showOnAxis":true},{"date":new Date(2014,4,14),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"B. Riley maintains AKAM to Buy. Target Price is $68.","showOnAxis":false},{"date":new Date(2014,4,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains AKAM to Overweight. Target Price is $67.5; previously $63.","showOnAxis":true},{"date":new Date(2014,4,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains AKAM to Hold. Target Price is $54; previously $52.","showOnAxis":true},{"date":new Date(2014,4,2),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains AKAM to Overweight. Target Price is $67.5; previously $63.","showOnAxis":false},{"date":new Date(2014,4,2),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Jefferies maintains AKAM to Hold. Target Price is $54; previously $52.","showOnAxis":false},{"date":new Date(2014,6,24),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Macquarie upgrades AKAM to Outperform from Neutral. Target Price is $70; previously $59.","showOnAxis":false},{"date":new Date(2014,6,30),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,6,30),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,6,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains AKAM to Neutral. Target Price is $50; previously $47.5.","showOnAxis":true},{"date":new Date(2014,6,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains AKAM to Overweight. Target Price is $73; previously $67.5.","showOnAxis":true},{"date":new Date(2014,6,31),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains AKAM to Neutral. Target Price is $50; previously $47.5.","showOnAxis":false},{"date":new Date(2014,6,31),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains AKAM to Overweight. Target Price is $73; previously $67.5.","showOnAxis":false},{"date":new Date(2014,7,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Baird initiates coverage on AKAM to Outperform. Target Price is $71.","showOnAxis":true},{"date":new Date(2014,7,27),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Baird initiates coverage on AKAM to Outperform. Target Price is $71.","showOnAxis":false},{"date":new Date(2014,8,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS initiates coverage on AKAM to Buy. Target Price is $70.","showOnAxis":true},{"date":new Date(2014,8,5),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS initiates coverage on AKAM to Buy. Target Price is $70.","showOnAxis":false},{"date":new Date(2014,9,22),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2014,9,22),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,9,29),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,9,29),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,9,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains AKAM to Neutral. Target Price is $52.5; previously $50.","showOnAxis":true},{"date":new Date(2014,9,30),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse maintains AKAM to Neutral. Target Price is $52.5; previously $50.","showOnAxis":false},{"date":new Date(2015,0,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"B. Riley downgrades AKAM to Neutral from Buy. Target Price is $69; previously $70.","showOnAxis":true},{"date":new Date(2015,0,9),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"B. Riley downgrades AKAM to Neutral from Buy. Target Price is $69; previously $70.","showOnAxis":false},{"date":new Date(2015,1,10),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,1,10),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,1,4),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,1,4),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,10,12),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,10,12),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,10,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs downgrades AKAM to Sell from Neutral. Target Price is $52; previously $62.","showOnAxis":true},{"date":new Date(2015,10,20),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs downgrades AKAM to Sell from Neutral. Target Price is $52; previously $62.","showOnAxis":false},{"date":new Date(2015,10,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Macquarie maintains AKAM to Neutral. Target Price is $65; previously $71.","showOnAxis":true},{"date":new Date(2015,10,3),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Macquarie maintains AKAM to Neutral. Target Price is $65; previously $71.","showOnAxis":false},{"date":new Date(2015,11,14),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Evercore ISI Group initiates coverage on AKAM to Buy. Target Price is $70.","showOnAxis":true},{"date":new Date(2015,11,14),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Evercore ISI Group initiates coverage on AKAM to Buy. Target Price is $70.","showOnAxis":false},{"date":new Date(2015,3,28),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,3,28),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,3,29),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Deutsche Bank upgrades AKAM to Buy from Hold.","showOnAxis":false},{"date":new Date(2015,3,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Canaccord Genuity maintains AKAM to Buy. Target Price is $78; previously $75.","showOnAxis":true},{"date":new Date(2015,3,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains AKAM to Overweight. Target Price is $75; previously $73.","showOnAxis":true},{"date":new Date(2015,3,29),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Canaccord Genuity maintains AKAM to Buy. Target Price is $78; previously $75.","showOnAxis":false},{"date":new Date(2015,3,29),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains AKAM to Overweight. Target Price is $75; previously $73.","showOnAxis":false},{"date":new Date(2015,3,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank initiates coverage on AKAM to Hold. Target Price is $73.","showOnAxis":true},{"date":new Date(2015,3,9),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank initiates coverage on AKAM to Hold. Target Price is $73.","showOnAxis":false},{"date":new Date(2015,4,13),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,4,13),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,13),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2015,4,19),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Oppenheimer downgrades AKAM to Perform from Outperform.","showOnAxis":true},{"date":new Date(2015,4,19),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains AKAM to Buy. Target Price is $88; previously $79.","showOnAxis":true},{"date":new Date(2015,4,19),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Oppenheimer downgrades AKAM to Perform from Outperform.","showOnAxis":false},{"date":new Date(2015,4,19),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains AKAM to Buy. Target Price is $88; previously $79.","showOnAxis":false},{"date":new Date(2015,5,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Macquarie initiates coverage on AKAM to Outperform. Target Price is $75; previously $77.","showOnAxis":true},{"date":new Date(2015,5,9),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Macquarie initiates coverage on AKAM to Outperform. Target Price is $75; previously $77.","showOnAxis":false},{"date":new Date(2015,6,21),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,6,21),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,6,28),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,6,28),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,6,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains AKAM to Buy. Target Price is $77; previously $79.","showOnAxis":true},{"date":new Date(2015,6,9),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains AKAM to Buy. Target Price is $77; previously $79.","showOnAxis":false},{"date":new Date(2015,7,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Pacific Crest assumes AKAM to Overweight. Target Price is $91.","showOnAxis":true},{"date":new Date(2015,7,20),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Pacific Crest assumes AKAM to Overweight. Target Price is $91.","showOnAxis":false},{"date":new Date(2015,7,28),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"JMP Securities upgrades AKAM to Market Outperform from Market Perform. Target Price is $85.","showOnAxis":false},{"date":new Date(2015,7,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains AKAM to Buy. Target Price is $80; previously $77.","showOnAxis":true},{"date":new Date(2015,7,31),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains AKAM to Buy. Target Price is $80; previously $77.","showOnAxis":false},{"date":new Date(2015,9,27),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,9,27),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,9,28),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"B. Riley maintains AKAM to Neutral. Target Price is $64; previously $66.","showOnAxis":true},{"date":new Date(2015,9,28),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Canaccord Genuity downgrades AKAM to Hold. Target Price is $65.","showOnAxis":true},{"date":new Date(2015,9,28),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Cowen & Co. downgrades AKAM to Market Perform from Outperform.","showOnAxis":true},{"date":new Date(2015,9,28),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Craig-Hallum downgrades AKAM to Hold from Buy.","showOnAxis":true},{"date":new Date(2015,9,28),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan downgrades AKAM to Neutral from Overweight. Target Price is $65; previously $75.","showOnAxis":true},{"date":new Date(2015,9,28),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Morgan Stanley maintains AKAM to Equal-Weight. Target Price is $70; previously $75.","showOnAxis":true},{"date":new Date(2015,9,28),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Pacific Crest maintains AKAM to Overweight. Target Price is $86; previously $91.","showOnAxis":true},{"date":new Date(2015,9,28),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"B. Riley maintains AKAM to Neutral. Target Price is $64; previously $66.","showOnAxis":false},{"date":new Date(2015,9,28),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Canaccord Genuity downgrades AKAM to Hold. Target Price is $65.","showOnAxis":false},{"date":new Date(2015,9,28),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Cowen & Co. downgrades AKAM to Market Perform from Outperform.","showOnAxis":false},{"date":new Date(2015,9,28),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Craig-Hallum downgrades AKAM to Hold from Buy.","showOnAxis":false},{"date":new Date(2015,9,28),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan downgrades AKAM to Neutral from Overweight. Target Price is $65; previously $75.","showOnAxis":false},{"date":new Date(2015,9,28),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Morgan Stanley maintains AKAM to Equal-Weight. Target Price is $70; previously $75.","showOnAxis":false},{"date":new Date(2015,9,28),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Pacific Crest maintains AKAM to Overweight. Target Price is $86; previously $91.","showOnAxis":false},{"date":new Date(2015,9,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"FBR Capital downgrades AKAM to Underperform.","showOnAxis":true},{"date":new Date(2015,9,29),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"FBR Capital downgrades AKAM to Underperform.","showOnAxis":false},{"date":new Date(2016,0,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"KeyBanc maintains AKAM to Outperform. Target Price is $75; previously $86.","showOnAxis":true},{"date":new Date(2016,0,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Pacific Crest maintains AKAM to Outperform. Target Price is $75; previously $86.","showOnAxis":true},{"date":new Date(2016,0,11),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"KeyBanc maintains AKAM to Outperform. Target Price is $75; previously $86.","showOnAxis":false},{"date":new Date(2016,0,11),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Pacific Crest maintains AKAM to Outperform. Target Price is $75; previously $86.","showOnAxis":false},{"date":new Date(2016,1,10),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"B. Riley upgrades AKAM to Buy.","showOnAxis":false},{"date":new Date(2016,1,10),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Craig-Hallum upgrades AKAM to Buy.","showOnAxis":false},{"date":new Date(2016,1,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse assumes AKAM to Neutral. Target Price is $45.","showOnAxis":true},{"date":new Date(2016,1,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains AKAM to Buy. Target Price is $75; previously $80.","showOnAxis":true},{"date":new Date(2016,1,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"FBR Capital maintains AKAM to Underperform. Target Price is $42; previously $49.","showOnAxis":true},{"date":new Date(2016,1,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains AKAM to Neutral. Target Price is $60; previously $65.","showOnAxis":true},{"date":new Date(2016,1,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"KeyBanc maintains AKAM to Outperform. Target Price is $71; previously $75.","showOnAxis":true},{"date":new Date(2016,1,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains AKAM to Buy. Target Price is $55; previously $65.","showOnAxis":true},{"date":new Date(2016,1,10),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Credit Suisse assumes AKAM to Neutral. Target Price is $45.","showOnAxis":false},{"date":new Date(2016,1,10),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Deutsche Bank maintains AKAM to Buy. Target Price is $75; previously $80.","showOnAxis":false},{"date":new Date(2016,1,10),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"FBR Capital maintains AKAM to Underperform. Target Price is $42; previously $49.","showOnAxis":false},{"date":new Date(2016,1,10),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"JP Morgan maintains AKAM to Neutral. Target Price is $60; previously $65.","showOnAxis":false},{"date":new Date(2016,1,10),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"KeyBanc maintains AKAM to Outperform. Target Price is $71; previously $75.","showOnAxis":false},{"date":new Date(2016,1,10),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"UBS maintains AKAM to Buy. Target Price is $55; previously $65.","showOnAxis":false},{"date":new Date(2016,1,3),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,1,3),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,1,9),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,1,9),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,10,7),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2016,10,7),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,11,14),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Oppenheimer upgrades AKAM to Outperform from Perform. Target Price is $70; previously $65.","showOnAxis":false},{"date":new Date(2016,11,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Guggenheim initiates coverage on AKAM to Buy. Target Price is $75.","showOnAxis":true},{"date":new Date(2016,11,22),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Guggenheim initiates coverage on AKAM to Buy. Target Price is $75.","showOnAxis":false},{"date":new Date(2016,2,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"RBC Capital initiates coverage on AKAM to Sector Perform. Target Price is $62.","showOnAxis":true},{"date":new Date(2016,2,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus initiates coverage on AKAM to Hold.","showOnAxis":true},{"date":new Date(2016,2,24),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"RBC Capital initiates coverage on AKAM to Sector Perform. Target Price is $62.","showOnAxis":false},{"date":new Date(2016,2,24),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus initiates coverage on AKAM to Hold.","showOnAxis":false},{"date":new Date(2016,3,26),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, AKAM reports 2016 Q1's earning $0.66 per share and revenue $567.725MM. This beats analyst's estimated EPS $0.63, beats estimated revenue $563.81MM.","showOnAxis":false},{"date":new Date(2016,3,26),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,3,26),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,3,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Baird maintains AKAM to Outperform. Target Price is $60; previously $62.","showOnAxis":true},{"date":new Date(2016,3,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Craig-Hallum downgrades AKAM to Hold from Buy.","showOnAxis":true},{"date":new Date(2016,3,27),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Baird maintains AKAM to Outperform. Target Price is $60; previously $62.","showOnAxis":false},{"date":new Date(2016,3,27),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Craig-Hallum downgrades AKAM to Hold from Buy.","showOnAxis":false},{"date":new Date(2016,4,11),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2016,6,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"SunTrust Robinson Humphrey initiates coverage on AKAM to Buy. Target Price is $66.","showOnAxis":true},{"date":new Date(2016,6,21),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"SunTrust Robinson Humphrey initiates coverage on AKAM to Buy. Target Price is $66.","showOnAxis":false},{"date":new Date(2016,6,26),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, AKAM reports 2016 Q2's earning $0.64 per share and revenue $572.135MM. This meets analyst's estimated EPS $0.64, misses estimated revenue $574.86MM.","showOnAxis":false},{"date":new Date(2016,6,26),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,6,26),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,6,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs maintains AKAM to Sell. Target Price is $47; previously $43.","showOnAxis":true},{"date":new Date(2016,6,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Pacific Crest downgrades AKAM to Sector Weight from Overweight.","showOnAxis":true},{"date":new Date(2016,6,27),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Goldman Sachs maintains AKAM to Sell. Target Price is $47; previously $43.","showOnAxis":false},{"date":new Date(2016,6,27),"type":"sign","text":"N","backgroundColor":"#ADE6C4","graph":"g1","description":"Pacific Crest downgrades AKAM to Sector Weight from Overweight.","showOnAxis":false},{"date":new Date(2016,7,10),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,7,10),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,7,12),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Wells Fargo upgrades AKAM to Outperform from Market Perform.","showOnAxis":false},{"date":new Date(2016,9,25),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, AKAM reports 2016 Q3's earning $0.68 per share and revenue $584.065MM. This beats analyst's estimated EPS $0.61, beats estimated revenue $571.92MM.","showOnAxis":false},{"date":new Date(2016,9,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,9,25),"type":"sign","text":"K","backgroundColor":"#E6ADD9","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,9,26),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"FBR Capital upgrades AKAM to Market Perform from Underperform.","showOnAxis":false},{"date":new Date(2017,1,7),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, AKAM reports 2016 Q4's earning $0.72 per share and revenue $616.124MM. This beats analyst's estimated EPS $0.68, beats estimated revenue $605.19MM.","showOnAxis":false}];